Gross-to-Net (GTN) waterfall model for the US and EU
|

3. How to Build a Pharma Gross-to-Net (GTN) Waterfall

Ever look at your paycheck? There’s the big “gross pay” number, and then the much smaller “net pay” that actually hits your bank account. The gap is filled with taxes, insurance, and other deductions. A pharma company’s revenue works the same way. This workshop is about that gap. (This is the third post in our…

Learn how pharma market access works in the US vs. Europe
|

2. Who Decides if a New Drug Gets Paid For? (A Guide for Investors)

A new drug just won FDA approval. The stock pops. But hold the champagne. Getting a regulator’s safety and efficacy stamp is just graduating from medical school. Now comes the real world: convincing the people with the money—insurers and governments—to actually pay for it. This is market access. (In our last post, we followed the…

1. Pharma’s Money Maze: Where Drug Dollars Disappear in the US vs. Europe

Ever look at a drug’s price and wonder where the money actually goes? A pill travels from the factory to your pharmacy, and along the way, a whole ecosystem of middlemen takes a cut. But the size of those cuts—and who gets them—is wildly different in the US versus Europe. Let’s follow the money. The…

Copper prices are surging
|

The Copper Crunch: Why Your Electric Car Dreams Are Getting More Expensive

And other inconvenient truths about the metal that powers our green future Remember when we all thought going electric would be simple? Buy a Tesla, install some solar panels, pat ourselves on the back for saving the planet. Well, I’ve got some news that might make your eco-friendly wallet a little lighter: we’re running out…

The Great Small-Cap Mystery:
|

The Great Small-Cap Mystery: How Python Revealed Wall Street’s Best-Kept Secret

You know that feeling when you’re scrolling through your phone and suddenly see something that makes you do a double-take? That’s exactly what happened to me last week while running some Python code on small-cap stocks. The numbers were so extreme, I thought my script was broken. Spoiler alert: it wasn’t. The Tale of Two…

Dot Com Bubble and AI Boom
|

Is AI the New Gold Rush? The Truth About Tech’s Latest Obsession

Why everyone from your CEO to your barista is suddenly an AI expert—and what history tells us about where this is all heading Remember when your uncle Steve started day-trading dot-com stocks in 1999? When he quit his accounting job to become a “digital entrepreneur” and insisted that Pets.com was going to revolutionize pet ownership…

NVIDIA vs. AMD: The AI Chip War That Will Change Your Life
|

NVIDIA vs. AMD: The AI Chip War That Will Change Your Life

You know that feeling when you’re at the grocery store, and you see a new brand of your favorite cereal right next to the one you always buy? And it’s not only cheaper, but the box says it has 50% more of those little marshmallow things you love? That’s basically what’s happening right now in…

A Waymo self-driving Jaguar I-PACE robotaxi navigating a sunlit city street in mid-2025, showcasing the advanced LiDAR and camera sensors on its roof, representing its lead in the autonomous vehicle race against competitors like Tesla.
|

Waymo is Quietly Winning the Robotaxi Race. So Why Is Everyone Watching Tesla?

One of my friends tried to hail a robotaxi in Austin last week. Not for a real ride, but as an experiment. One app promised a futuristic utopia, a car summoned by a tap, part of a grand vision from the world’s most famous tech CEO. The other app… well, it was just Uber. But…

|

My Python Bot Tried a Famous Stock Market ‘Glitch’. It Didn’t Go As Planned.

You know that feeling? The one you get right after a company like Apple or Nvidia drops its quarterly earnings report. You see the headline: “EARNINGS BEAT!” The stock pops 5% after hours. You think, “Duh, of course. The company is printing money.” You go to bed feeling smart. Then you wake up, and the…

CPI detective analyzing inflation data with Python
|

The Hook: When Your Coffee Bill Becomes a Crime Scene

Last Tuesday, I walked into my usual coffee shop and nearly choked—not on the espresso, but on the price. My regular medium latte had jumped from $3.75 to $5.25 compared to a few months back. Five dollars and twenty-five cents! For coffee! Standing there, clutching my overpriced caffeine lifeline, a question hit me: Are prices really going…